ALK Positive Lung Cancer: Clinical Profile, Practice and Outcomes in a Developing Country.

OBJECTIVES:To evaluate the performance and treatment profile of advanced EML4-ALK positive Non-small cell lung cancer (NSCLC) patients in a developing country with potentially restricted access to Crizotinib. MATERIALS AND METHODS:A retrospective analysis of advanced ALK positive NSCLC patients who...

Full description

Bibliographic Details
Main Authors: Vanita Noronha, Anant Ramaswamy, Vijay M Patil, Amit Joshi, Anuradha Chougule, Subhadha Kane, Rajiv Kumar, Arvind Sahu, Vipul Doshi, Lingaraj Nayak, Abhishek Mahajan, Amit Janu, Kumar Prabhash
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2016-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC5026380?pdf=render